The Lost Decade: Neglect for Harm Reduction Funding and the Health Crisis among People who Use Drugs. Cook C and Davies C. (2018)

immage

In Harm Reduction International’s 2010 report on the state of global funding for harm reduction, we stressed, ‘more money is needed for harm reduction, and it is needed now’. Sadly, this statement remains true in 2018. Harm reduction interventions for people who use drugs—such as needle and syringe programmes (NSP) and opioid substitution therapy (OST)—are cost-effective, protect against HIV and hepatitis C, and save lives. Despite the potential for these interventions to contribute to healthier communities, funding for harm reduction in lowand middle-income countries (LMICs) has flat-lined over the past decade.

 


Keywords: HIV/AIDS, LMICs, harm reduction, funding

 

 

Download Publication

Police and Harm Reduction. Krupanski M. (2018)

immage

Globally, law enforcement officers have grown increasingly frustrated with the limited effectiveness of traditional drug enforcement approaches that find them arresting or imprisoning individuals without significant impact on illicit drug trade or use. This is a briefing for law enforcement personnel around the world on how to incorporate, support, and create space for approaches that aim to increase public safety and health, reduce harm to people who use drugs, and provide law enforcement alternatives to common punitive models.

 

Keywords: Community strengthening, criminal justice, harm reduction

 

 

Download Publication

Wilton Park 2018: Slowing the HIV and Hepatitis C (HCV) Epidemic for People who Inject Drugs. Wilton Park. (2018)

immage

Participants from many parts of the world, with different expertise and engagements with the Human Immunodeficiency Virus (HIV) and the Hepatitis C Virus (HCV) gathered at the Wilton Park facility of the United Kingdom Foreign and Commonwealth Office (FCO) on 26-28 February 2018 to consider ways of slowing the epidemics amongst people who inject drugs (PWIDs).

This meeting provided a timely opportunity to explore the impact of key global frameworks on reaching PWID with HIV and HCV prevention, treatment and care measures one year prior to the 2019 United Nations General Assembly Special Session on Drugs (UNGASS) to be held in New York. This report provides an overview of presentations and discussions, highlighting the most salient themes that emerged from the meeting.

 

Keywords: HIV/AIDS, human rights, hepatitis, harm reduction

 

Download Publication

The 9th Asian Informal Drug Policy Dialogue. Transnational Institute. (2018)

immage

In regards to current drug trends, particularly methamphetamine (both in crystal and pill form) has become increasingly accessible and affordable throughout Asia, reflecting the trend of rising use of amphetamine-type stimulants (ATS) in the region.

Governments in the SEA region have implemented different kinds of national drug policy reform, including diversion programmes (Indonesia and Cambodia), harm reduction measures (Malaysia and Myanmar), and steps towards decriminalisation of cannabis cultivation and use for medical and scientific purposes (Thailand).

 


Keywords: community, harm reduction, treatment, drugs

 

Download Publication

Voicing Community Interests in the Global Fund. Global Network of People Living with HIV and Asian Pacific Network of People Living with HIV/AIDS. (2018)

image

This handbook aims to facilitate the active involvement of PLHIV in the GFATM CCM. It outlines basic values and principles, providing practical information and tools which can be adapted to national contexts. It stresses the ongoing importance of PLHIVled communication, coordination and consultation, so that people most affected by the three diseases can continually make their voices heard and weigh in on important issues. The ultimate goal of PLHIV representation on CCMs is to ensure that GFATM financed programs are efficient, impactful and sustainable.

 


Keywords: HIV/AIDS, PLHIV, civil society, guidelines

 

 

Download Document

Undetectable = Untransmittable — Public Health and HIV Viral Load Suppression. UNAIDS. (2018)

immage

Twenty years of evidence demonstrates that HIV treatment is highly effective in reducing the transmission of HIV. People living with HIV on antiretroviral therapy who have an undetectable level of HIV in their blood have a negligible risk of transmitting HIV sexually.

 


Keywords: HIV, ART, PLHIV, treatment

 

 

Download Publication

Update on Antiretroviral Regimens for Treating and Preventing HIV Infection and Update on Early Infant Diagnosis of HIV: Interim Guidance. WHO. (2018)

immage

Update on antiretroviral regimens for treating and preventing HIV infection: Since 2016, WHO has recommended tenofovir disoproxil fumarate (TDF) + lamivudine (3TC) (or emtricitabine, FTC) + efavirenz (EFV) 600 mg as the preferred first- line antiretroviral therapy (ART) regimen for adults and adolescents. WHO recommended dolutegravir (DTG) as an alternative option to EFV for first-line ART because of the uncertainty regarding the safety and efficacy of DTG during pregnancy and among people living with HIV receiving rifampicin-based tuberculosis (TB) treatment.

 

Update on early infant diagnosis of HIV: In 2016, WHO recommended that HIV virological testing be used to diagnose HIV infection among infants and children younger than 18 months and that ART be started without delay while a second specimen is collected to confirm the initial positive virological test result.

 

Keywords: HIV, ART, diagnosis, treatment

 

 

Download Publication

HIV/AIDS and ART Registry of the Philippines: June 2018. Epidemiology Bureau, Department of Health. (2018)

immage

In June 2018, there were 993 new HIV antibody seropositive individuals reported to the HIV/AIDS & ART Registry of the Philippines (HARP) [Table 1]. Eighteen percent (174) had clinical manifestations of advanced HIV infection (WHO clinical stage 3 or 4) at the time of diagnosis.

 


Keywords: HIV, AIDS cases, ART, PLHIV, mode of transmission, newly diagnosed

 

 

Download Publication

HIV/AIDS and ART Registry of the Philippines: May 2018. Epidemiology Bureau, Department of Health. (2018)

immage

In May 2018, there were 950 new HIV antibody seropositive individuals reported to the HIV/AIDS & ART Registry of the Philippines (HARP). Seventeen percent (166) had clinical manifestations of advanced HIV infection (WHO clinical stage 3 or 4) at the time of diagnosis.

 

Keywords: HIV, AIDS cases, ART, PLHIV, mode of transmission, newly diagnosed

 

 

Download Publication

Regional and Country Snapshots 2018. UNAIDS Regional Support Team for Asia and the Pacific and AIDS Data Hub. (2018)

image

The regional and country snapshots prepared by UNAIDS Regional Support Team for Asia and the Pacific and AIDS Data Hub provides information on the HIV epidemic and response.

 

Keywords: HIV, new infections, prevalence, PMTCT, treatment, finance, stigma, laws

 

Download Snapshots


- Regional Snapshot 2018: HIV Epidemic in Asia and the Pacific

 

- Country Snapshot 2018: Afghanistan

 

- Country Snapshot 2018: Bangladesh

 

- Country Snapshot 2018: Cambodia

 

- Country Snapshot 2018: China

 

- Country Snapshot 2018: Fiji

 

- Country Snapshot 2018: India

 

- Country Snapshot 2018: Indonesia

 

- Country Snapshot 2018: Lao PDR

 

- Country Snapshot 2018: Malaysia

 

- Country Snapshot 2018: Mongolia

 

- Country Snapshot 2018: Myanmar

 

- Country Snapshot 2018: Nepal

 

- Country Snapshot 2018: Pakistan

 

- Country Snapshot 2018: Papua New Guinea

 

- Country Snapshot 2018: Philippines

 

- Country Snapshot 2018: Sri Lanka

 

- Country Snapshot 2018: Thailand

 

- Country Snapshot 2018: Viet Nam

Pages

database
Highlighted publications
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Nepal_National_Community_Led_HIV_Testing_Guidelines_2018.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_IBBS_PWID_PWUD_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_IBBS_FEW_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/DataHub_TB-HIV_Fact_Sheet_2018.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_Global_AIDS_Monitoring_2018.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/NSACP_Sri_Lanka_National_HIV_Communication_Strategy_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_Status_of_National_AIDS_Response_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V1_North-East_region_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V2_West_South_region_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V3_Northern_Central_Eastern_region_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_Annual_report_2016-17.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_Estimations_and_projections_of_HIV_AIDS_at_Sub-national_level_2016-2020.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_HIV_drug_resistance_report_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guidelines_on_public_health_response_to_pretreatment_HIV_drug_resistance_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guidelines_for_Managing_Advanced_HIV_Disease_and_Rapid_Initiation_of_ART_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_What_New_in_Treatment_Monitoring_Viral_Load_and_CD4_Testing_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Pakistan_IBBS_2016-17.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Pakistan_Mapping_Key_Populations_2015-16.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_Global_AIDS_Update_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_Global_AIDS_Update_2017_Data_2017_en.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Myanmar_National_Strategic_Plan_on_HIV_and_AIDS_2016-2020.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_2017_Global_AIDS_Monitoring_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Nepal-IBBS-FIDU-Kathmandu-valley-RI-2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_methods_for_deriving_estimates_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/2015_Size_Estimation_of_Key_Affected_Populations_in_Philippines.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Assessment_of_Decentralization_of_ART_in_MMR_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS-2016-prevention-gap-report_en.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Implementing_comprehensive_HIV_and_STI_programmes_with_transgender_people_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_cities_ending_the_aids_epidemic_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Philippines_2015_IHBSS_Fact_Sheets_Nov2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Consolidated_on_the_use_of_antiretroviral_drugs_for_treating_and_preventing_HIV_infection_2016.pdf
Calendar of events